nodes	percent_of_prediction	percent_of_DWPC	metapath
Vardenafil—PDE5A—clitoris—adrenal gland cancer	0.319	0.66	CbGeAlD
Vardenafil—PDE11A—adrenal gland—adrenal gland cancer	0.0302	0.0625	CbGeAlD
Vardenafil—PDE6G—adrenal gland—adrenal gland cancer	0.0291	0.0602	CbGeAlD
Vardenafil—PDE1B—gonad—adrenal gland cancer	0.0223	0.0462	CbGeAlD
Vardenafil—PDE10A—adrenal gland—adrenal gland cancer	0.0196	0.0407	CbGeAlD
Vardenafil—PDE1B—adrenal gland—adrenal gland cancer	0.0195	0.0403	CbGeAlD
Vardenafil—CYP3A4—urine—adrenal gland cancer	0.0187	0.0388	CbGeAlD
Vardenafil—PDE5A—gonad—adrenal gland cancer	0.0132	0.0273	CbGeAlD
Vardenafil—PDE5A—adrenal gland—adrenal gland cancer	0.0115	0.0238	CbGeAlD
Vardenafil—PDE1B—Downstream signaling of activated FGFR—PRKACA—adrenal gland cancer	0.00307	0.00593	CbGpPWpGaD
Vardenafil—PDE11A—Hemostasis—SPARC—adrenal gland cancer	0.00303	0.00585	CbGpPWpGaD
Vardenafil—PDE1B—EGFR interacts with phospholipase C-gamma—EGFR—adrenal gland cancer	0.00302	0.00583	CbGpPWpGaD
Vardenafil—PDE1B—PLCG1 events in ERBB2 signaling—EGFR—adrenal gland cancer	0.00295	0.0057	CbGpPWpGaD
Vardenafil—PDE1B—Downstream signal transduction—PRKACA—adrenal gland cancer	0.00288	0.00558	CbGpPWpGaD
Vardenafil—PDE1B—G alpha (s) signalling events—GNAS—adrenal gland cancer	0.00288	0.00557	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR—PRKACA—adrenal gland cancer	0.00287	0.00555	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by ERBB2—PRKACA—adrenal gland cancer	0.00286	0.00552	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 signaling—PRKACA—adrenal gland cancer	0.00284	0.00549	CbGpPWpGaD
Vardenafil—PDE6G—Disease—SH3KBP1—adrenal gland cancer	0.00274	0.00531	CbGpPWpGaD
Vardenafil—PDE1B—Opioid Signalling—POMC—adrenal gland cancer	0.00273	0.00527	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—SPARC—adrenal gland cancer	0.0027	0.00522	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—SPARC—adrenal gland cancer	0.0027	0.00522	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR in disease—PRKACA—adrenal gland cancer	0.00267	0.00517	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 interactions—PRKACA—adrenal gland cancer	0.00267	0.00517	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR—PRKACA—adrenal gland cancer	0.00265	0.00512	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR in Cancer—PRKACA—adrenal gland cancer	0.00263	0.00508	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by PDGF—PRKACA—adrenal gland cancer	0.00261	0.00506	CbGpPWpGaD
Vardenafil—PDE6G—Disease—ZNRF3—adrenal gland cancer	0.00258	0.00499	CbGpPWpGaD
Vardenafil—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—adrenal gland cancer	0.00257	0.00496	CbGpPWpGaD
Vardenafil—PDE11A—Hemostasis—PRKACA—adrenal gland cancer	0.00255	0.00494	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00252	0.00488	CbGpPWpGaD
Vardenafil—PDE6G—beta-catenin independent WNT signaling—CTNNB1—adrenal gland cancer	0.0025	0.00484	CbGpPWpGaD
Vardenafil—PDE1B—NGF signalling via TRKA from the plasma membrane—PRKACA—adrenal gland cancer	0.00237	0.00458	CbGpPWpGaD
Vardenafil—PDE6G—Signaling by Wnt—TERT—adrenal gland cancer	0.00231	0.00447	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00229	0.00443	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—PRKACA—adrenal gland cancer	0.00228	0.0044	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—PRKACA—adrenal gland cancer	0.00228	0.0044	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—GNRHR—adrenal gland cancer	0.00226	0.00437	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00225	0.00435	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00225	0.00435	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR—CDC42—adrenal gland cancer	0.00225	0.00435	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR in Cancer—CDC42—adrenal gland cancer	0.00223	0.00431	CbGpPWpGaD
Vardenafil—PDE11A—Hemostasis—CDC42—adrenal gland cancer	0.00217	0.00419	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.0021	0.00406	CbGpPWpGaD
Vardenafil—PDE11A—Hemostasis—IGF2—adrenal gland cancer	0.00209	0.00404	CbGpPWpGaD
Vardenafil—PDE11A—Hemostasis—GNAS—adrenal gland cancer	0.00207	0.004	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—GNRHR—adrenal gland cancer	0.00207	0.004	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00204	0.00395	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—TSHR—adrenal gland cancer	0.00204	0.00395	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—GNRHR—adrenal gland cancer	0.00201	0.00389	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—TSHR—adrenal gland cancer	0.002	0.00388	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00198	0.00382	CbGpPWpGaD
Vardenafil—PDE1B—G alpha (s) signalling events—POMC—adrenal gland cancer	0.00194	0.00375	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—CDC42—adrenal gland cancer	0.00193	0.00373	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—CDC42—adrenal gland cancer	0.00193	0.00373	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00192	0.00372	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.0019	0.00368	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00187	0.00362	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—IGF2—adrenal gland cancer	0.00186	0.0036	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—IGF2—adrenal gland cancer	0.00186	0.0036	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—GNAS—adrenal gland cancer	0.00185	0.00357	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—GNAS—adrenal gland cancer	0.00185	0.00357	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—PRKACA—adrenal gland cancer	0.00182	0.00352	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—TSHR—adrenal gland cancer	0.00182	0.00352	CbGpPWpGaD
Vardenafil—PDE1B—Downstream signaling of activated FGFR—BAD—adrenal gland cancer	0.00182	0.00351	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00181	0.00349	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00176	0.0034	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00173	0.00334	CbGpPWpGaD
Vardenafil—PDE1B—Downstream signal transduction—BAD—adrenal gland cancer	0.00171	0.0033	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR—BAD—adrenal gland cancer	0.0017	0.00328	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by ERBB2—BAD—adrenal gland cancer	0.00169	0.00327	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 signaling—BAD—adrenal gland cancer	0.00168	0.00325	CbGpPWpGaD
Vardenafil—PDE6G—Disease—SPRY2—adrenal gland cancer	0.00162	0.00313	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR in disease—BAD—adrenal gland cancer	0.00158	0.00306	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 interactions—BAD—adrenal gland cancer	0.00158	0.00306	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR—BAD—adrenal gland cancer	0.00157	0.00303	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR in Cancer—BAD—adrenal gland cancer	0.00155	0.00301	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by PDGF—BAD—adrenal gland cancer	0.00155	0.00299	CbGpPWpGaD
Vardenafil—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00155	0.00299	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR—BRAF—adrenal gland cancer	0.00155	0.00299	CbGpPWpGaD
Vardenafil—PDE6G—Disease—MEN1—adrenal gland cancer	0.00148	0.00286	CbGpPWpGaD
Vardenafil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00147	0.00285	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—SH3KBP1—adrenal gland cancer	0.00147	0.00284	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00147	0.00283	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR in disease—BRAF—adrenal gland cancer	0.00144	0.00279	CbGpPWpGaD
Vardenafil—PDE1B—NGF signalling via TRKA from the plasma membrane—BAD—adrenal gland cancer	0.0014	0.00271	CbGpPWpGaD
Vardenafil—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00138	0.00267	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00137	0.00265	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—SPARC—adrenal gland cancer	0.00137	0.00264	CbGpPWpGaD
Vardenafil—PDE1B—Disease—SH3KBP1—adrenal gland cancer	0.00136	0.00262	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—GNRH1—adrenal gland cancer	0.00135	0.00262	CbGpPWpGaD
Vardenafil—PDE6G—Signaling by Wnt—CTNNB1—adrenal gland cancer	0.00132	0.00256	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00131	0.00253	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00131	0.00253	CbGpPWpGaD
Vardenafil—PDE1B—NGF signalling via TRKA from the plasma membrane—BRAF—adrenal gland cancer	0.00128	0.00247	CbGpPWpGaD
Vardenafil—PDE1B—Disease—ZNRF3—adrenal gland cancer	0.00127	0.00246	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—CDC42—adrenal gland cancer	0.00124	0.0024	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—SPRY2—adrenal gland cancer	0.00124	0.00239	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—GNRH1—adrenal gland cancer	0.00124	0.00239	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00122	0.00236	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—GNRH1—adrenal gland cancer	0.00121	0.00233	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—TSHR—adrenal gland cancer	0.00121	0.00233	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—GNAS—adrenal gland cancer	0.00119	0.0023	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00117	0.00225	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—PRKACA—adrenal gland cancer	0.00115	0.00223	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00114	0.0022	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—MEN1—adrenal gland cancer	0.00113	0.00219	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—SPRY2—adrenal gland cancer	0.00113	0.00219	CbGpPWpGaD
Vardenafil—PDE6G—Disease—PRKACA—adrenal gland cancer	0.00113	0.00219	CbGpPWpGaD
Vardenafil—CYP3A5—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00112	0.00216	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—CDC42—adrenal gland cancer	0.00111	0.00214	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—SPRY2—adrenal gland cancer	0.0011	0.00213	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—TSHR—adrenal gland cancer	0.0011	0.00213	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—BAD—adrenal gland cancer	0.00108	0.00208	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—TSHR—adrenal gland cancer	0.00108	0.00208	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—GNAS—adrenal gland cancer	0.00106	0.00205	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—PRKACA—adrenal gland cancer	0.00104	0.00201	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—MEN1—adrenal gland cancer	0.00104	0.00201	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00104	0.002	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—GNRHR—adrenal gland cancer	0.00102	0.00197	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00102	0.00196	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—MEN1—adrenal gland cancer	0.00101	0.00196	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—BRAF—adrenal gland cancer	0.000981	0.0019	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—CDC42—adrenal gland cancer	0.000979	0.00189	CbGpPWpGaD
Vardenafil—PDE6G—Disease—CDC42—adrenal gland cancer	0.000959	0.00186	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000949	0.00183	CbGpPWpGaD
Vardenafil—PDE1B—Downstream signaling of activated FGFR—EGFR—adrenal gland cancer	0.000947	0.00183	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—IGF2—adrenal gland cancer	0.000943	0.00182	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—GNAS—adrenal gland cancer	0.000935	0.00181	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—TSHR—adrenal gland cancer	0.000923	0.00178	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000892	0.00173	CbGpPWpGaD
Vardenafil—PDE1B—Downstream signal transduction—EGFR—adrenal gland cancer	0.00089	0.00172	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR—EGFR—adrenal gland cancer	0.000885	0.00171	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by ERBB2—EGFR—adrenal gland cancer	0.000881	0.0017	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—CDC42—adrenal gland cancer	0.000881	0.0017	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—POMC—adrenal gland cancer	0.000881	0.0017	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 signaling—EGFR—adrenal gland cancer	0.000877	0.0017	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—PRKACA—adrenal gland cancer	0.000866	0.00167	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR in disease—EGFR—adrenal gland cancer	0.000825	0.0016	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 interactions—EGFR—adrenal gland cancer	0.000825	0.0016	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR—EGFR—adrenal gland cancer	0.000818	0.00158	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR in Cancer—EGFR—adrenal gland cancer	0.00081	0.00157	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by PDGF—EGFR—adrenal gland cancer	0.000807	0.00156	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—POMC—adrenal gland cancer	0.0008	0.00155	CbGpPWpGaD
Vardenafil—PDE1B—Disease—SPRY2—adrenal gland cancer	0.000799	0.00154	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—PRKACA—adrenal gland cancer	0.000792	0.00153	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—POMC—adrenal gland cancer	0.000785	0.00152	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—PRKACA—adrenal gland cancer	0.000772	0.00149	CbGpPWpGaD
Vardenafil—PDE6G—Disease—TERT—adrenal gland cancer	0.00077	0.00149	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—CDC42—adrenal gland cancer	0.000735	0.00142	CbGpPWpGaD
Vardenafil—PDE1B—Disease—MEN1—adrenal gland cancer	0.000732	0.00141	CbGpPWpGaD
Vardenafil—PDE1B—NGF signalling via TRKA from the plasma membrane—EGFR—adrenal gland cancer	0.000731	0.00141	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—POMC—adrenal gland cancer	0.000713	0.00138	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—IGF2—adrenal gland cancer	0.000708	0.00137	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—GNAS—adrenal gland cancer	0.000702	0.00136	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—IGF1R—adrenal gland cancer	0.000685	0.00132	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CDC42—adrenal gland cancer	0.000672	0.0013	CbGpPWpGaD
Vardenafil—PDE6G—Disease—BAD—adrenal gland cancer	0.000669	0.00129	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000662	0.00128	CbGpPWpGaD
Vardenafil—PDE11A—Hemostasis—TP53—adrenal gland cancer	0.000662	0.00128	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CDC42—adrenal gland cancer	0.000655	0.00127	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—IGF2—adrenal gland cancer	0.000648	0.00125	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—GNAS—adrenal gland cancer	0.000642	0.00124	CbGpPWpGaD
Vardenafil—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000642	0.00124	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—IGF2—adrenal gland cancer	0.000631	0.00122	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—IGF1R—adrenal gland cancer	0.000626	0.00121	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—GNAS—adrenal gland cancer	0.000626	0.00121	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000619	0.0012	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—BAD—adrenal gland cancer	0.000615	0.00119	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—GNRH1—adrenal gland cancer	0.000611	0.00118	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—IGF1R—adrenal gland cancer	0.00061	0.00118	CbGpPWpGaD
Vardenafil—PDE6G—Disease—BRAF—adrenal gland cancer	0.000609	0.00118	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—PRKACA—adrenal gland cancer	0.000605	0.00117	CbGpPWpGaD
Vardenafil—CYP3A5—Biological oxidations—POMC—adrenal gland cancer	0.000594	0.00115	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000591	0.00114	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—TP53—adrenal gland cancer	0.00059	0.00114	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—TP53—adrenal gland cancer	0.00059	0.00114	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—TERT—adrenal gland cancer	0.000589	0.00114	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—EGFR—adrenal gland cancer	0.000562	0.00109	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—CDC42—adrenal gland cancer	0.000562	0.00109	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—SPRY2—adrenal gland cancer	0.000559	0.00108	CbGpPWpGaD
Vardenafil—PDE1B—Disease—PRKACA—adrenal gland cancer	0.000559	0.00108	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—TSHR—adrenal gland cancer	0.000545	0.00105	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—TERT—adrenal gland cancer	0.000539	0.00104	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—GNAS—adrenal gland cancer	0.000537	0.00104	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—SDHB—adrenal gland cancer	0.000531	0.00103	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—TERT—adrenal gland cancer	0.000525	0.00102	CbGpPWpGaD
Vardenafil—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00052	0.00101	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—CDC42—adrenal gland cancer	0.000513	0.000992	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—BAD—adrenal gland cancer	0.000513	0.000991	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—MEN1—adrenal gland cancer	0.000512	0.000991	CbGpPWpGaD
Vardenafil—PDE6G—Disease—PTGS2—adrenal gland cancer	0.000492	0.000952	CbGpPWpGaD
Vardenafil—PDE1B—Disease—CDC42—adrenal gland cancer	0.000474	0.000916	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—POMC—adrenal gland cancer	0.000473	0.000914	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—BAD—adrenal gland cancer	0.000469	0.000907	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—BRAF—adrenal gland cancer	0.000467	0.000902	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—BAD—adrenal gland cancer	0.000457	0.000883	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—EGFR—adrenal gland cancer	0.000452	0.000875	CbGpPWpGaD
Vardenafil—PDE6G—Disease—CTNNB1—adrenal gland cancer	0.00044	0.000852	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—POMC—adrenal gland cancer	0.000432	0.000836	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—BRAF—adrenal gland cancer	0.000427	0.000825	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—POMC—adrenal gland cancer	0.000421	0.000814	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—BRAF—adrenal gland cancer	0.000416	0.000804	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—CTNNB1—adrenal gland cancer	0.000405	0.000782	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—EGFR—adrenal gland cancer	0.000403	0.00078	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—POMC—adrenal gland cancer	0.000398	0.000769	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PRKACA—adrenal gland cancer	0.000391	0.000756	CbGpPWpGaD
Vardenafil—PDE1B—Disease—TERT—adrenal gland cancer	0.00038	0.000735	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—POMC—adrenal gland cancer	0.000361	0.000699	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—BAD—adrenal gland cancer	0.000358	0.000693	CbGpPWpGaD
Vardenafil—PDE6G—Disease—EGFR—adrenal gland cancer	0.000349	0.000675	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—RRM1—adrenal gland cancer	0.000342	0.000662	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—SDHD—adrenal gland cancer	0.000342	0.000662	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000337	0.000652	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CDC42—adrenal gland cancer	0.000332	0.000642	CbGpPWpGaD
Vardenafil—PDE1B—Disease—BAD—adrenal gland cancer	0.000331	0.000639	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—EGFR—adrenal gland cancer	0.000321	0.00062	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—IGF2—adrenal gland cancer	0.00032	0.000618	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—GNAS—adrenal gland cancer	0.000317	0.000613	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—IGF1R—adrenal gland cancer	0.000309	0.000598	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000308	0.000596	CbGpPWpGaD
Vardenafil—PDE1B—Disease—BRAF—adrenal gland cancer	0.000301	0.000582	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000301	0.000581	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—TP53—adrenal gland cancer	0.000299	0.000578	CbGpPWpGaD
Vardenafil—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	0.000276	0.000534	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—EGFR—adrenal gland cancer	0.000267	0.000517	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—TERT—adrenal gland cancer	0.000266	0.000515	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—MED12—adrenal gland cancer	0.000255	0.000494	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—SDHB—adrenal gland cancer	0.000247	0.000478	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—EGFR—adrenal gland cancer	0.000244	0.000473	CbGpPWpGaD
Vardenafil—PDE1B—Disease—PTGS2—adrenal gland cancer	0.000243	0.00047	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—EGFR—adrenal gland cancer	0.000238	0.00046	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—CTNNB1—adrenal gland cancer	0.000236	0.000456	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—BAD—adrenal gland cancer	0.000232	0.000448	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—TP53—adrenal gland cancer	0.000224	0.000434	CbGpPWpGaD
Vardenafil—PDE1B—Disease—CTNNB1—adrenal gland cancer	0.000218	0.000421	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—POMC—adrenal gland cancer	0.000213	0.000413	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—BRAF—adrenal gland cancer	0.000211	0.000408	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—TP53—adrenal gland cancer	0.000205	0.000397	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—EGFR—adrenal gland cancer	0.000204	0.000395	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—TP53—adrenal gland cancer	0.0002	0.000387	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—EGFR—adrenal gland cancer	0.000187	0.000361	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PRKACA—adrenal gland cancer	0.000186	0.00036	CbGpPWpGaD
Vardenafil—PDE1B—Disease—EGFR—adrenal gland cancer	0.000172	0.000333	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—SDHD—adrenal gland cancer	0.000159	0.000308	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—RRM1—adrenal gland cancer	0.000159	0.000308	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000152	0.000295	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GNAS—adrenal gland cancer	0.000151	0.000292	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ABCB1—adrenal gland cancer	0.000148	0.000286	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—EGFR—adrenal gland cancer	0.000121	0.000233	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—MED12—adrenal gland cancer	0.000119	0.00023	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—POMC—adrenal gland cancer	0.000102	0.000197	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—TP53—adrenal gland cancer	0.000101	0.000196	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	8.66e-05	0.000167	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PTGS2—adrenal gland cancer	8.11e-05	0.000157	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GNAS—adrenal gland cancer	7.02e-05	0.000136	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	6.89e-05	0.000133	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—POMC—adrenal gland cancer	4.73e-05	9.14e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	3.77e-05	7.29e-05	CbGpPWpGaD
